Regenics vs Hers: compounded options vs FDA-approved Wegovy®
Regenics vs Hers comes down to compounded medications and lower promotional pricing versus FDA-approved brand options and a membership model. Early verdict: choose Regenics for lower first-month compounded prices and a Sermorelin add-on; choose Hers for FDA-approved Wegovy® and structured dose check-ins.
Explore Regenics pricing and options
How they differ: compounded products versus FDA-approved brand drugs
Regenics offers compounded semaglutide and tirzepatide prepared by U.S. licensed compounding pharmacies and shipped with free shipping, while Hers promotes FDA-approved Wegovy® and brand-name GLP-1 options and explicitly states it does not offer compounded medications. Regenics cautions that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Hers highlights Wegovy® and Zepbound® as FDA-approved for weight loss and notes some drugs like Ozempic® are approved for type 2 diabetes and may be prescribed off-label at a clinician’s discretion.
What that means for patients
Both platforms require a licensed clinician to determine whether treatment is medically appropriate. Regenics is nurse-practitioner-led and emphasizes its LegitScript certified compounding pharmacy network. Hers emphasizes doctor-trusted, FDA-approved name-brand GLP-1s and a personalized care team with ongoing dose check-ins.
Pricing model and cost details compared
Price structure is a major practical difference. Regenics advertises promotional first-month pricing: semaglutide $139 first month (renews $199/mo) and tirzepatide $189 first month. Hers lists Wegovy® from $149/mo and shows medication pricing that may be offered from $149 to higher amounts depending on drug, but an active Hers Weight Loss Membership is required, starting $39 for the first month and auto-renewing at $149/month thereafter. Hers notes membership and medication are billed separately and that medication is not available without an active membership.
See Hers membership and medication pricing
Care model and clinical oversight
Regenics provides nurse-practitioner-led GLP-1 care where licensed nurse practitioners review intake before anything is prescribed. Hers offers a personalized care team with ongoing dose check-ins and positions itself as doctor-trusted for FDA-approved GLP-1s. Both stress that treatment is available only when a licensed clinician determines it is medically appropriate.
Unique features and add-ons
Regenics includes a Sermorelin peptide therapy add-on and lists a 15mg injectable peptide priced at $399 in captured FAQ evidence. Hers focuses on brand-name GLP-1s and does not offer compounded alternatives. Regenics also notes FSA/HSA eligibility and free shipping with medication compounded in the USA. Hers emphasizes name-brand medication with no compounded product offered and states not all treatments are available in all states.
Availability and enrollment considerations
Hers warns that some products are not available in all 50 states and that prescriptions are subject to clinical eligibility. Regenics notes treatment is available only when a licensed clinician determines it is medically appropriate, but the captured Regenics landing page did not verify state availability or membership requirements. Hers also specifies that membership is required to access medication and that pricing shown may include medication only if prescribed.
Comparison summary table
| Criteria | Regenics | Hers |
|---|---|---|
| Medication type | Compounded semaglutide and tirzepatide | FDA-approved Wegovy® and brand-name GLP-1s, not compounded |
| Starting price (captured) | Semaglutide $139 first month; tirzepatide $189 first month | Wegovy® from $149/mo; membership required |
| Ongoing fees | Semaglutide renews at $199/mo; tirzepatide at $279/mo per FAQ | Membership required: $39 first month then auto-renews at $149/mo |
| Clinical oversight | Licensed nurse practitioners review intake before prescription | Personalized care team with ongoing dose check-ins |
| Add-ons | Sermorelin peptide therapy available | No compounded or peptide add-ons advertised |
| Regulatory note | Compounded meds are not FDA-approved finished products | Promotes FDA-approved Wegovy® and notes some drugs are off-label for weight loss |
Which to choose: final guidance
Regenics vs Hers is a choice between compounded, lower promotional first-month pricing with a peptide add-on and nurse-practitioner-led telehealth care, versus FDA-approved brand-name GLP-1s with a membership and structured dose check-ins. Choose Regenics if you want a cash-pay, compounded semaglutide or tirzepatide entry point with Sermorelin available and the promotional first-month pricing. Choose Hers if you want FDA-approved Wegovy® or other brand-name GLP-1 options with a personalized care team and ongoing dose check-ins and you accept a required membership.
Start with Regenics compound options
Start Hers with Wegovy® and care team
Compare Regenics plans and Sermorelin
Regenics vs Hers: consider whether compounded pricing, a Sermorelin add-on, and nurse-practitioner oversight or FDA approval, brand-name GLP-1s, and a membership better match your needs. Treatment availability and prescriptions are subject to clinician review and state limitations where noted.